VEINOPLUS® is a prescription neuromuscular electrical stimulation device. Among its cleared indications: prevention or retardation of muscle disuse atrophy.
Interventional pain, physiatry and PM&R.
Prevention or retardation of muscle disuse atrophy.
At home, seated, operated by the patient on a prescribed schedule.
Chronic pain drives activity avoidance. Lumbar radiculopathy, post-laminectomy syndrome, peripheral neuropathy, chronic lower-extremity pain — each of them reduces a patient's daily step count, month over month.
The gastrocnemius and soleus are no longer being asked to work. What is left is disuse atrophy of the calf: measurable circumference loss, weakness and a deconditioned limb — in a leg whose motor supply is still intact.
Where the disuse has a non-neurological cause and the motor supply is intact, prevention or retardation of muscle disuse atrophy is a cleared indication for this device.
Electrodes are placed over the calf. The device produces rhythmic, visible contractions of the gastrocnemius and soleus while the patient is seated — no gym, no weight-bearing requirement, and nothing the patient has to be able to walk to do.
A brisk visible contraction on an in-office trial demonstrates that the motor supply is intact.
A lower-extremity pain patient with declining ambulation and visible or measurable calf wasting.
Place electrodes over the calf and confirm a brisk visible gastrocnemius / soleus contraction.
Calf circumference and side-to-side asymmetry, the functional decline in ambulation, the non-neurological cause of the disuse, and the trial response.
Home-use protocol. C2 Medical handles fulfilment and patient set-up — nothing is stocked or fitted in your office.
Relaxation of muscle spasms; prevention or retardation of muscle disuse atrophy; increasing local blood circulation; muscle re-education; immediate post-surgical stimulation of calf muscles to prevent venous thrombosis; maintaining or increasing range of motion.
Cardiac pacemaker or other implanted electronic device. Active DVT at the treatment site. Severe arterial insufficiency. Uncontrolled congestive heart failure.
Low-intensity impulses, with a waveform designed for patient comfort during stimulation. Reported skin reactions are rare, mild and self-limiting. The device is non-invasive, drug-free and patient-administered.
Ten peer-reviewed publications and 49 international congress presentations are reported by DynaPulse Medical. Selected references are listed below for reference only; full texts are available on request.
No. The device ships to the patient. Nothing is held or managed by the practice.
Only the in-office trial. There is no fitting appointment and no supervised treatment session.
No. It is used alongside the plan you already set, for the patient who cannot yet tolerate ambulation-based reconditioning.
The instructions for use, indication details, a coverage and documentation reference, and ordering information — all available on request.
Instructions for use, indication details, the coverage and documentation reference, and ordering information. Clinicians and practice staff can request them directly.
Email C2 Medical